COVID-19 is an emerging, rapidly evolving situation.

• Latest COVID-19 public health information from the U.S. Centers for Disease Control and Prevention (CDC)
• Latest COVID-19 research information from the U.S. National Institutes of Health (NIH)
• COVID-19 resources for global health researchers from Fogarty

---

Malaria news, resources and funding for global health researchers

Malaria is a mosquito-borne disease causing fever, chills and flu-like illness that can be fatal. Despite an increased focus on malaria, it still claims hundreds of thousands of lives each year, most of them children in Africa. Poor quality antimalarial drugs, which lead to drug resistance and inadequate treatment, are also a growing concern, posing an urgent threat to vulnerable populations.

Fogarty has supported a wide range of efforts to combat malaria, including the Multilateral Initiative on Malaria, an international effort to identify and address malaria research priorities. Ecology and Evolution of Infectious Diseases, a joint NIH - National Science Foundation (NSF) initiative, funds malaria-related projects in Kenya, Papua New Guinea, Belize and more. Through the Global Infectious Disease program, Fogarty has supported research training efforts that advance scientific discoveries, while developing local malaria research capacity in places where it's needed most.

Fogarty's epidemiology division studies malaria transmission patterns, drug resistance and other related topics, modeling malaria's prevalence and impact.

Top News

• World Malaria Day 2020: Zero malaria starts with me
  NIAID Now blog, April 24, 2020
• World Malaria Day 2020: CDC and partners continue the fight against a global killer
  CDC news, April 24, 2020
• Assessment of long-term health effects of antimalarial drugs when used for prophylaxis
  National Academies of Sciences, Engineering and Medicine, 2020
• Profile: Fogarty Fellow Jillian Armstrong studies novel malaria detection device in Cameroon
  January / February 2020 Global Health Matters
• NIH study supports new approach for treating cerebral malaria
  NINDS/NIH news, February 18, 2020
• First human trial of monoclonal antibody to prevent malaria opens
  NIH trial will test NIAID-developed antibody
  NIAID/NIH news, January 27, 2020
• Malaria eradication within a generation: ambitious, achievable and necessary
  Lancet Commission, September 8, 2019
• Falsified and substandard drugs: Stopping the pandemic [Free access], co-authored by Dr Joel Breman, Fogarty senior scientific adviser emeritus
  American Journal of Tropical Medicine and Hygiene, May 1, 2019
• Poor quality drugs for treating malaria, pneumonia, hypertension and other diseases pose “public health emergency,” study says
  Mar / Apr 2019 Global Health Matters
• Early stage clinical trial of antimalarial drug begins
  NIAID/NIH news, September 10, 2018
• NIH researchers identify sequence leading to release of malaria parasites from red blood cells
  NICHD/NIH news, July 11, 2018
• Tagging essential malaria genes to advance drug development
  Blog post by NIH Director Dr. Francis S. Collins, May 15, 2018
• Essential malaria parasite genes revealed
  NIAID/NIH news, May 3, 2018
• Newly described human antibody prevents malaria in mice
  NIAID/NIH news, March 19, 2018
• NIH study identifies new targets for anti-malaria drugs
  NICHD/NIH news, October 26, 2017
• NIH funds seven International Centers of Excellence for Malaria Research that work in 14 countries in Africa, Asia and Latin America
  NIAID/NIH news, April 21, 2017
• NIH begins study of vaccine to protect against mosquito-borne diseases
  NIAID/NIH news, February 21, 2017
• Experimental PfSPZ malaria vaccine provides durable protection against multiple strains in NIH clinical trial
  NIAID/NIH news, February 21, 2017
• Related publication: PfSPZ vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection
  PNAS, February 21, 2017 (online)
• Investigational PfSPZ malaria vaccine demonstrates considerable protection in Malian adults for duration of malaria season
  NIAID/NIH news, February 16, 2017
• Related publication: Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial
  The Lancet Infectious Diseases, February 15, 2017 (online)
• Raising the curtain on cerebral malaria's deadly agents
  NINDS/NIH news, December 6, 2016
• Investigational malaria vaccine protects healthy U.S. adults for more than one year
  NIAID/NIH news, May 9, 2016
• Testing curbs malaria drug misuse in Kenya
  Jan / Feb 2016 Global Health Matters

Related Fogarty News and Information

• Chinese researchers discovered effectiveness of artemisinin against malaria
  Sep / Oct 2015 Global Health Matters
• Global pandemic of fake medicines poses urgent risk, scientists say
  May / Jun 2015 Global Health Matters
• Related publications: The Global Pandemic of Falsified Medicines: Laboratory and Field Innovations and Policy Perspectives
  June 2015 supplement to the American Journal of Tropical Medicine and Hygiene, published online April 20, 2015
• Q and A with world-renowned malaria research expert Dr Chris Plowe
  May / Jun 2015 Global Health Matters
• Fogarty Global Infectious Diseases grantee news:
  An American doctor may have solved a deadly mystery about malaria
  PRI's The World, May 5, 2015
• Study shows parasite mutation behind drug-resistant malaria in Cambodia
  Jan / Feb 2014 Global Health Matters
• WHO urges artemisinin resistance testing
  Jan / Feb 2014 Global Health Matters
• Fogarty funding spurs global health innovations, including a project to develop low-cost malaria diagnostics in Zambia
  Nov / Dec 2013 Global Health Matters
• Fogarty funds ecology, genetics studies of malaria in Ghana
  Nov / Dec 2013 Global Health Matters
• Malaria vaccine is safe, effective
  Sep / Oct 2013 Global Health Matters
• Investigational malaria vaccine found safe and protective: NIH vaccine researchers publish results of early-stage clinical trial
  NIH / NIAID news release, August 8, 2013
• Fogarty grantee news: African fever patients commonly over-diagnosed with malaria
  Duke Global Health Institute News, July 18, 2013
• FDA acts against compromised antimalarial drugs
  May / Jun 2013 Global Health Matters
• NIH partners with FDA: FDA launches partnership to protect against counterfeit anti-malarial medicines with FDA-developed handheld detection tool
  FDA News, April 24, 2013

• Resistance to malaria drugs is a growing concern
  Sep / Oct 2012 Global Health Matters
• Related publication: Counterfeit antimalarial drugs
  The Lancet Infectious Diseases, November 2012
• Artemisinin-Resistant Malaria: Research Challenges, Opportunities, and Public Health Implications
  Meeting report on Fogarty and NIAID conference on artemisinin-resistant malaria
  American Society of Tropical Medicine and Hygiene, August 2012
• Fogarty study shows poor quality and fake malaria drugs pose threat
  May / Jun 2012 Global Health Matters
• NIH study shows poor quality malaria drugs pose threat, Drug resistance a growing concern in Southeast Asia and sub-Saharan Africa
  NIH News, May 21, 2012
• Call to action on drug-resistant malaria
  Fogarty/NIH News, September 22, 2011
• Something new under the sea: promising malaria treatment found in Fiji
  Mar / Apr 2011 Global Health Matters
• Research in viral diseases aims at ending malaria
  Jan / Feb 2011 Global Health Matters
• Artesunate suppositories are economical, effective for malaria treatment
  Nov / Dec 2010 Global Health Matters
• Studying malaria and bioethics in Mali
  Jul / Aug 2010 Global Health Matters
• Deadly malaria parasite came from chimps
  Sep / Oct 2009 Global Health Matters
• Cognitive Deficits Linked to Cerebral Malaria in Children
  May / Jun 2008 Global Health Matters
• Deforestation impacts spread of infectious diseases in Peruvian Amazon
  Mar / Apr 2008 Global Health Matters
• Jan / Feb 2008 Global Health Matters focus on malaria:
• Genetically engineered mosquitoes may aid in the fight against malaria
• Latest malaria research published in supplement edited by Fogarty scientist
• Scientists seport that misdiagnosis of malaria is common
• DDT's ongoing role in malaria control examined
• Low-cost synthetic form of artemisinin may provide solution in malaria battle
• Top malaria experts publish groundbreaking research to aid malaria eradication
  Fogarty/NIH News, January 7, 2008

NIH News and Resources

• National Institute of Allergy and Infectious Diseases (NIAID) Malaria Topic Page
• National Library of Medicine (NLM)'s MedlinePlus on Malaria

Other US Government Resources

• President's Malaria Initiative (PMI)
• U.S. President's Malaria Initiative's Thirteenth Annual Report to Congress, published May 2019
• Centers for Disease Control and Prevention (CDC): Malaria
• Food and Drug Administration (FDA)
• FDA launches partnership to protect against counterfeit anti-malarial medicines with FDA-developed handheld detection tool
  FDA news release, April 24, 2013
• Related publication: Evaluation of a New Handheld Instrument for the Detection of Counterfeit Artesunate by Visual Fluorescence Comparison
  American Journal of Tropical Medicine and Hygiene (online), September 29, 2014
• U.S. Agency for International Development (USAID): Malaria

Other Online Resources

• Malaria Foundation International
• PATH Malaria Vaccine Initiative
• Population Services International - Malaria Information
• Roll Back Malaria Partnership (RBM)
• Together Against Malaria
• World Health Organization on Malaria